Andy Thompson Flashcards

(68 cards)

1
Q

Nitrogen mustards

A

Draw mechanism of action

Direct ring alkylation leads to a positively charged adduct that is liable to depurination and strand break

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Nucleophilic sites on DNA

A

i.e. the sites of DNA alkylation
Guanine N7, N3, exocyclic NH2
Adenine N7, N3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mustard gas

A

Too toxic for human use

Draw

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chlormethine

A

Aliphatic mustard, sufficient therapeutic index for human use
Draw

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Chlorambucil

A

Aromatic mustard
Less electrophilic, reacts with DNA more slowly
Can be administered orally
Draw

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Melphalan

A

Rationale for synthesis = enhance cellular uptake via Phe uptake mechanism
(draw)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cyclophosphamide

A

Rationale for synthesis = release mustard agent through enzymatic degradation
(draw)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Estramustine

A

Rationale for synthesis = target oestrogen-dependent tumour cells
(draw)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Temozolomide

A

DNA-methylating compound

Draw mechanism of activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Repair of DNA methylation by temozolomide

A

Methylation occurs on guanine O6
The DNA alkyltransferase enzyme AGT scans dsDNA for alkylation on guanine O6
Covalent transfer of the alkyl group to the conserve active site Cys in AGT restores guanine to normal (and inactivates AGT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What can happen if a G-CH3 lesion is not repaired?

A

2 things can happen:

  1. Transversion = G to A transition mutation
  2. Strand break
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DNA minor groove binders

A

Can bind covalently or non-covalently
Flat, planar, poly-aromatic structures - many also have a natural twist to fit into the groove
Alkylate a base within the mono groove
Secondary, non-covalent interactions are important in covalent binding
Some non-covalent compounds have been modified with DNA alkylation moieties (e.g. mustards, epoxides) to give experimental covalent compounds
Many covalent compounds have been linked to give dimer intra- and inter strand cross linkers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Covalent minor groove binders

A

Mitomycin C
Cyclopropapyrroloindoles (CPIs)
Pyrrolo-1,4-benzodiazepines (PBDs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Non-covalent minor groove binders

A

Distamycin

Netropsin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mitomycin C

A

Undergoes enzymatic or chemical reductive activation
Primary alkylation sites are guanine N2 and N7 in the DNA minor groove
Draw mechanism of alkylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

(+)-CC-1065

A

(draw)
CPI-based anti-tumour antibiotic
Ethanobridges cause DNA over-winding, leading to dose-limiting toxicity and delayed death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Adozelesin

A

Ethanobridges in CC-1065 removed
Adozelesin is effective but difficult to synthesise
(draw)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Bizelesin

A

Dimer of adozelesin
This allows 2 alkylation reactions to occur, therefore can form inter strand DNA cross-links
Very insoluble but very potent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

High-field NMR studies on Adozelesin

A

Palindromic sequences used CGATTAATCG
Adozelesin binds at 2nd A (one adozelesin on each strand)
NMR showed the formation of 2 duplex adducts, which were both basically the same except one had Watson-Crick base pairing between the middle TA/AT and one had Hoogsteen base pairing
i.e. there were 2 base pair arrangements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

High-field NMR studies on Bizelesin

A

Palindromic sequences used CGATTAATCG
One Bizelesin molecule forms inter stand cross-link at A
NMR showed 2 base pair arrangements: 1. Watson-Crick, 2. Open base pairing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Effect of open base pairing on DNA repair

A

Open base pairs (or Hoogsteen) affect the arrangement of bases
Open base pairing means the major groove is filled with bases and actually no longer a groove
The damage is no longer just within the minor groove - this contributes to the increased potency of Bizelesin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

PBD-based anti-tumour antibiotics

A

Tomayamycin
Anthramycin
Sibiromycin

These 3 compounds are all naturally-occurring anti-tumour antibiotics, but none have been adopted clinically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Mechanism of action of tomayamycin with DNA

A

(draw)

Involves the formation of a reversible animal bond between the exocyclic NH2 of guanine and C11 on PBD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Reactive form of PBD compounds

A

PBD compounds are traditionally recrystallised with MeOH to give the stable methyl ether
Methyl ether imine carbinolamine
All 3 forms can react with DNA but it is widely considered that the immune/carbinolamine are the active forms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
DC-81
Synthesised in the search for better PBD-based compounds
26
DSB-120
Dimer of DC-81
27
AT-486
More active PBD dimer but more difficult to synthesise
28
SJG-136
PBD dimer Compromise in terms of reactivity and synthetic viability Currently in the clinic Potent anti-tumour and antibiotic - a "last line treatment" for MRSA
29
High-field NMR studies on SJG-136 DNA duplex adducts
SJG-136 can form inter- and intrastrand cross-links, but intrastrand are preferred
30
Next steps for DNA alkylators...
Use pro-drugs so damage is restricted to the tumour Hypoxia-based targeting Use of antibodies Tumour cells have increased permittivity DNA-specific structural targets e.g. telomeres/promoters
31
Bleomycins
A group of related basic glycopeptides that differ in the terminal amine substituent of the common structural unit (bleomycin acid) Generally active against most tumours Bind Fe(I) or Cu(I) and O2 - can catalyse the formation of ss and dsDNA lesions in the presence of a one-electron reductant Similar damage to that generated by ionising radiation In vitro studies indicate that a single molecule of bleomycin is sufficient to generate lesions on both DNA strands
32
Common outcomes of bleomycin treatment
Extended cell cycle arrest Apoptosis Mitotic cell death
33
Regions of the bleomycin molecule
The total bleomycin molecule is greater than the sum of its parts The linker region between the metal-binding domain and the bithiazole DNA-binding domain, as well as the flexibility of the bithiazole moiety itself are essential for efficient dsDNA cleavage
34
Why are bleomycins unable to cross the cell membrane by free diffusion?
They are hydrophilic | Studies indicate the positively charged tail might play a key role in cellular uptake
35
Sites of dsDNA cleavage by bleomycins
Bleomycins firstly initiate ssDNA cleavage at pyrimidines 3' to a guanine in a sequence-specific fashion The secondary site of cleavage depends on the primary cleavage site: 5'-G-Py-Pu-3' sequences = bleomycins generate 5' staggered ends 5'-G-Py-Py-3' sequences = bleomycins generate blunt ends
36
Mechanism for dsDNA cleavage by bleomycins
dsDNA cleavage by a single bleomycin molecule requires the reorganisation and reactivation of bleomycin during or after cleavage of the first strand of DNA in order to allow cleavage of the second strand The key to this reorganisation is believed to be the linker and the flexibility of the bithiazole tail (bound by partial intercalation) Rotation around the bond between the 2 thiazole rings in the bleomycin tail make the peroxide of the activated drug available for interaction with the second DNA strand
37
DNA DSB repair
There are several pathways to ensure the repair of DSBs in eukaryotic cells, but homologous recombination is the only inherently error-free pathway
38
Homologous recombination
1. Homologous recombination is initiated by a DSB caused by an endonuclease/DNA-damaging agent 2. DSB formation triggers cell cycle checkpoints through activation of ATM kinase 3. The DNA ends are recognised by Rad52 protein 4. The DNA is processed at the breakage site to yield regions of ssDNA 5. Rad51 polymerises onto the ssDNA with the help of Rad52 and RPA (amongst other proteins) to form a nucleoprotein filament 6. This "Rad51 nucleoprotein filament" searches for homologous sequences on the homologous chromosome/sister chromatid 7. DNA strand exchange occurs, generating a joint molecule between the homologous damaged and undamaged DNAss 8. The break is repaired by DNA polymerases, using the intact strand as a template 9. Ligation and resolution of the recombination intermediates results in accurate DSB repair
39
Other methods for DSB repair
Non-homologous end joining Break-induced replication ...but these are error-prone and can lead to deletion/insertion mutations - no regard for homology However, NHEJ is the major DSB repair pathway because it can occur at any point during the cell cycle and doesn't require a homologous chromosome Homologous recombination can only occur later S phase/early G2 when the sister chromatid is in close proximity
40
Nucleotide Excision Repair
Operates on base damage cause by exogenous agents e.g. mutagenic/carcinogenic chemicals that alter the chemistry and structure of the DNA duplex Involves the excision of damaged bases as part of an oligonucleotide fragment
41
Steps in nucleotide excision repair
1. The recognition of base damage during NER requires disruption of the normal Watson-Crick base pairing and altered chemistry in the damaged strand, typically involving the bases 2. DNA damage is recognised by the XPC-R23 complex 3. The binding of XPC-R23 to the DNA is followed by the binding of several other proteins including XPA (3' endonuclease), RPA, TFIIH and XPG 4. Recruitment of ERCC1-XPF (another endonuclease) completes the NER complex and cuts the damaged strand at junctions 5' to the site of base damage 5. This bimodal incision generates an oligonucleotide fragment approx. 25-30 nucleotides in length that includes the damaged base 6. The fragment is excised from the genome and the nucleotide gap is restored by repair synthesis involving DNA polymerase and its accessory replication proteins 7. The covalent integrity of the damaged strand is restored by DNA ligase
42
Base Excision Repair
Removes and replaces the majority of damaged DNA bases
43
Steps in base excision repair
1. The N-glycosidic bond of the damaged base is cleaved by a DNA glycosylase, leaving an abasic site in the DNA 2. The sugar-phosphate backbone of the basic site is then cleaved by a bifunctional glycosylase or an AP-endonuclease 3. If necessary, the 3' strand break end is converted into an OH to allow DNA polymerase to reinsert new bases 4. Synthesis of a single base = short patch BER, synthesis of several bases = long patch BER 5. The 5' single strand end of the ss break intermediate is then processed to allow for ligation by DNA ligases
44
Mechanism of action of cis-platin
Intracellular activation through substitution of the Cl groups by H2O The resulting species can then covalently bind to DNA, forming DNA adducts The major bis-adduct formed involves adjacent guanines on the same DNA strand (intrastrand cross-link) The minor bis-adduct formed involves guanines on opposite DNA strands (interstrand cross-link) Preferential binding occurs on guanine N7
45
Effect of cis-platin binding to DNA
The adducts cause unwinding/bending of the DNA | The final cellular outcome is generally apoptotic cell death/prolonged cell cycle arrest
46
What tumour types is cis-platin effective against?
Testicular/ovarian cancer But is notoriously toxic to the kidneys :( so a less-toxic analogue that retained anti-cancer activity needed to be developed
47
Tumour resistance to cis-platin/carboplatin
Mediated by inadequate levels of Pt reaching the target DNA | Tumour cells acquire resistance resulting in reduced Pt accumulation
48
Mechanisms of tumour resistance to cis-platin
1. Cis-platin causes a down-regulation of CTR1 expression in human ovarian cancer cell lines. CTR1 = transporter = substantial role in cis-platin influx. Loss of CTR1 means cis-platin must rely on passive diffusion to enter the cell (slow, because cis-platin is highly polar) 2. ATPA7A/B = efflux proteins involved in Cu transport. Human ovarian cancer cells transfected with ATP7A showed resistance to cis-platin and carboplatin due to Pt sequestration in vesicles 3. Increased cytoplasmic levels of glutathione/metallothioneins - these thiol-containing species bind to Pt (soft) before it can bind to DNA.
49
Conjugation of glutathione to cis-platin
Catalysed by GSTs (glutathione S-transferases) | Compound is made more anionic so is more readily exported from the cell by the GS-X pump
50
How do tumour cells mediate Pt resistance after DNA binding?
DNA repair Removal of adducts Tolerance mechanisms
51
What is believed to cause the increased sensitivity of testicular cancer to cis-platin?
A deficiency in DNA repair
52
Major pathway for removing cis-platin lesions from DNA
NER | Cis-platin resistant cancer cells show increased NER, associated with an increased expression/activity of ERCC1 and XPF
53
4 major DNA repair pathways
NER BER MMR DSB repair
54
Enhanced replicative bypass
Another tolerance mechanism to cis-platin | Certain DNA polymerases can bypass cis-platin-DNA adducts by "translesion synthesis"
55
Ongoing strategies to circumvent cisplatin and carboplatin resistance
Increase delivery of Pt to tumour e.g. using liposomes Combine existing Pt drugs with molecularly-targeted agents e.g. Avastin (bevacuzimab), Herception (trastuzumab) Use novel platinum drugs that target resistance mechanisms e.g. oxaliplatin
56
Oxaliplatin
Can circumvent cisplatin-mediated resistance | draw
57
Function of diaminocyclohexane group in oxaliplatin
Provides increased resistance to cells producing glutathione
58
Topoisomerases
Participate in the over- or underwinding of DNA
59
Type I topoisomerases
Cut one strand of the DNA helix, leading to relaxation Allows the molecule to rotate around uncut strand which reduces stress The cut strand can then be re-ligated
60
Type 2 topoisomerases
Cuts both strands of the DNA helix, passes another unbroken DNA helix through the gap then re-ligates the cut strands
61
How do most clinically active drugs that target TOP2 kill cells?
By trapping an enzyme intermediate ("covalent complex") | This generates enzyme-mediated DNA damage e.g. strand breaks, proteins covalently bound to DNA
62
Important side effect associated with targeting TOP2 with TOP2 poisons
Formation of secondary malignancies that arise from drug-induced translocations i.e. patients treated with these drugs have a reasonably higher chance of developing secondary tumours
63
Doxorubucin
(draw) = adriamycin Intercalator - inserts between planar DNA bases, distorting DNA structure Targets TOP2
64
Structure of intercalators
Many flat, planar rings (min. 3) that can insert into major and minor grooves via non-covalent interactions Have some sequence preference (i.e. preferred insertion sites)
65
Neighbour-exclusion principle
The 2 neighbouring sites of an occupied intercalation site in DNA must remain unoccupied Every second intercalation site along the length of the DNA double helix remains unoccupied
66
Why can telomeres form G quadruplexes?
Because they are G-rich
67
Equilibrium between dsDNA of telomeric sequence and G-quadruplex
Dependent upon chaperone proteins required for G-quadruplex formation and helicases that unwind the quadruplex
68
Drugs that interact with G-quadruplexes
Inhibit helicases e.g. cationic porphyrins | Sequester newly-formed G-quadruplexes e.g. telomestatin